Last reviewed · How we verify

NCT06349603

Physiotherapy Approach for Susac Syndrome

Completed Last updated 5 April 2024
What this trial tests

trial in Susac Syndrome in 1 participant. Completed in 6 April 2023.

Timeline
13 February 2023
Primary endpoint
1 April 2023
6 April 2023

Quick facts

Lead sponsorRehabilitation Centre Zivot
StatusCompleted
Study typeOBSERVATIONAL
Enrollment1
Start date13 February 2023
Primary completion1 April 2023
Estimated completion6 April 2023
Sites1 location across Bosnia and Herzegovina

Conditions studied

Sponsor

Rehabilitation Centre Zivot

Who can join

Eligibility, any sex, with Susac Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Susac's syndrome is a rare autoimmune disorder characterised by a triad of encephalopathy (brain dysfunction), branch retinal artery occlusion (loss of vision) and sensorineural hearing loss. This study presents the case of a patient undergoing intensive physiotherapy intervention following an injury, focusing on assessments such as volume and range of motion measurements, manual muscle tests, and pain intensity evaluations using various scales.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Rehabilitation Centre Zivot trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06349603.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing